[144] CALIX, INC. SEC Filing

Rhea-AI Filing Summary

Calix, Inc. (NYSE: CALX) filed a Form 144 indicating a proposed sale of 25,000 common shares through Wells Fargo Clearing Services. The block, acquired via stock-option exercise on 30-Jan-2023, carries an aggregate market value of $1.38 million and is slated for sale on or after 28-Jul-2025. With 65.3 million shares outstanding, the transaction would represent roughly 0.04 % of total shares, suggesting minimal dilution or market overhang. A related entity, Crescentico Trust, sold an identical 25,000-share block on 28-Apr-2025 for $0.99 million. The filer affirms no non-public adverse information and states compliance with Rule 10b5-1 provisions.

Insights

Securities Analyst

TL;DR – Small planned insider sale; negligible ownership impact, sentiment neutral.

The 25 k-share sale is valued at $1.38 M—about 0.04 % of CALX’s float—so liquidity impact should be immaterial. Form 144 signals intent, not certainty of execution, and no price or timing commitments beyond the earliest sale date. Compared with average daily volume, the block can be absorbed easily. Prior 25 k sale in April shows the seller using an orderly liquidation approach, likely under a 10b5-1 plan. Absent other disclosures, I view the filing as routine and not indicative of strategic shift or operational weakness.

Corporate Governance Expert

TL;DR – Routine Rule 144 notice; governance compliance intact, low investor relevance.

The notice satisfies SEC Rule 144 transparency, confirming the insider’s representation of no undisclosed material information. The use of a major broker and reference to 10b5-1 protections indicate adherence to best-practice insider-trading controls. Size and cadence of sales suggest personal diversification rather than a governance red flag. Consequently, governance risk remains unchanged.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Wells Fargo Clearing Services One North Jefferson Avenue St. Louis MO 63103	25000	1383666.99	65303995	07/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2023	Stock Options	Issuer			25000	01/30/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Crescentico Trust 2777 Orchard Parkway San Jose CA 95134	Calix, Inc.	04/28/2025	25000	988406.24

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Calix (CALX) shares are proposed for sale in this Form 144?

The filer plans to sell 25,000 common shares of Calix.

What is the aggregate market value of the shares in the Calix Form 144 filing?

The block is valued at $1,383,666.99 based on prevailing market data included in the form.

When is the earliest sale date for the Calix shares under Rule 144?

The approximate sale date listed is 28 July 2025.

How does the planned sale compare to Calix's total shares outstanding?

The 25,000 shares equal roughly 0.04 % of the 65.3 million shares outstanding.

Was there a recent prior sale by the same party?

Yes. A 25,000-share block was sold on 28 April 2025 for $988,406.24 in gross proceeds.